PBAC Report - Options for listing PD-(L)1 checkpoint inhibitors for multiple cancer indications on the PBS

22 March 2019 - The PBAC Report to the Minister for Health on “Options for listing PD(L)-1 checkpoint inhibitors for multiple ...

Read more →

Private health insurance costs the biggest household spending concern, survey finds

19 March 2019 - Private health insurance costs have overtaken electricity bills as the biggest household spending worry, according to ...

Read more →

Three new drugs added to PBS to ease cost pain

19 March 2019 - Three new treatments to help save or prolong the lives of thousands of Australians suffering from ...

Read more →

New early breast cancer drug to reduce risk of recurrence or death approved for Australian women

18 March 2019 - Nerlynx (neratinib) now approved by the Therapeutic Goods Administration for Australian women. ...

Read more →

Brexit - implications for therapeutic goods in Australia

18 March 2019 - In the event of a 'no deal' exit of the United Kingdom from the European Union, ...

Read more →

What 1 April 2019 private health insurance changes mean for you

17 March 2019 - When the calendar flips to April 1 this year, many private health insurance customers will need ...

Read more →

'Have you got insurance?': the US style question finding its way to Australian hospitals

16 March 2019 - “Have you got insurance?” It is the first question faced by any patient walking into a ...

Read more →

PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals)

15 March 2019 - The Public Summary Documents (first time rejections and deferrals) from the November 2018 PBAC meeting are now ...

Read more →

Vertex receives approval for Symdeko (tezacaftor/ivacaftor and ivacaftor) in Australia, to treat the underlying cause of cystic fibrosis in people aged 12 and older with certain CFTR gene mutations

12 March 2019 - A new treatment option for patients with two copies of the F508del mutation, the most common mutation ...

Read more →

Vulnerable and shocked: patients targeted by hospital revenue push

11 March 2019 - A new mum hours out of surgery and suffering from blood loss was badgered by the ...

Read more →

Health funds warn they will be on life support without premium relief

10 March 2019 - Health funds are warning membership rates will plummet to 30% and some insurers will go out ...

Read more →

Health insurers battle public hospitals over $1billion a year cash grab

11 March 2019 - Hospital patients are getting caught in the middle of a battle between public hospitals and private ...

Read more →

Direct-acting anti-virals for hepatitis C - outcome statement

8 March 2019 - The outcome statement for the direct-acting anti-virals for hepatitis C stakeholder meeting held on 13 December 2018 ...

Read more →

Continued support for Australia’s community pharmacies

8 March 2019 - The Australian Government has announced key measures to support the delivery of medicines and important patient services ...

Read more →

Can Netflix show Americans how to cut the cost of drugs?

5 March 2019 - Australia seems to have found a way to entice Big Pharma into making essential new medicines affordable. ...

Read more →